Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
· 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
metastatic castration resistant prostate cancer, 68ga-psma pet/ct positive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
#1048144
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
#1048145
Magic Camp for Children With Hemiplegic Cerebral Palsy
#1048147
Impact of Different Restorative Treatments for Deep Caries Lesion in Primary Teeth
#1048148
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty
#1048152
Record
· ID 845327
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.